Description

1H-Pyrrolo[2,3-B]Pyridine-5-Carboxylicacid,1-[(4-Methoxyphenyl)Methyl]- is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant commercial interest for its role as a key building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and manufacturers in the pharmaceutical and biotechnology sectors engaged in drug discovery and development programs.

Application

• Pharmaceutical Intermediate: Serves as a critical precursor in the synthesis of complex drug molecules, particularly in oncology and central nervous system (CNS) therapeutic areas.
• Drug Discovery Research: Used as a scaffold or building block in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Active Pharmaceutical Ingredient (API) Development: Incorporated into the synthetic route for novel APIs targeting specific biological pathways.
• Biochemical Research: Employed as a standard or reagent in biochemical assays and pharmacological studies.
• Contract Manufacturing (CMO): Supplied to contract manufacturing organizations for the production of clinical trial materials and commercial-scale APIs.

Basic Information

Product Name	1H-Pyrrolo[2,3-B]Pyridine-5-Carboxylicacid,1-[(4-Methoxyphenyl)Methyl]-
CAS No.	1201324-15-3
Molecular Formula	C16H14N2O3
Molecular Weight	282.30 g/mol
Synonyms	1-[(4-Methoxyphenyl)methyl]-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid; 1-(4-Methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid; 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methoxyphenyl)methyl]-; 1201324-15-3; UNII-9L3G8P2M8F; 9L3G8P2M8F; SCHEMBL21806427; DTXSID90664669
EINECS	Contact for details

Quality Control

Our production of 1H-Pyrrolo[2,3-B]Pyridine-5-Carboxylicacid,1-[(4-Methoxyphenyl)Methyl]- adheres to stringent quality management systems, ensuring batch-to-batch consistency and high purity suitable for pharmaceutical research. All materials are accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles as determined by advanced analytical techniques. We support compliance with cGMP and ICH Q7 guidelines for intermediates intended for pharmaceutical use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.